Abstract
A series of amino-substituted \(\alpha \)-cyanostilbene derivatives and their bile acid (cholic and deoxycholic acid) amides were designed and synthesized. A comparative study on the anticancer and antibacterial activity evaluation on the synthesized analogs was carried against the human osteosarcoma (HOS) cancer cell line, and two gram −ve (E. coli and S. typhi) and two gram \(+\)ve (B. subtilis and S. aureus) bacterial strains. All the cholic acid \(\alpha \)-cyanostilbene amides showed an \(\hbox {IC}_{50}\) in the range 2–13 \(\upmu \hbox {M}\) against human osteosarcoma cells (HOS) with the most active analog (6g) possessing an \(\hbox {IC}_{50}\) of \(2\,\upmu \hbox {M}\). One of the amino-substituted \(\alpha \)-cyanostilbene, 4e, was found to possess an \(\hbox {IC}_{50}\) of \(3\,\upmu \hbox {M}\). An increase in the number of cells at the sub-\(\hbox {G}_{1}\) phase of the cell was observed in the in vitro cell cycle analysis of two most active compounds in the series (4e, 6g) suggesting a clear indication toward induction of apoptotic cascade. With respect to antibacterial screening, amino-substituted \(\alpha \)-cyanostilbenes were found to be more active than their corresponding bile acid amides. The synthesized compounds were also subjected to in silico study to predict their physiochemical properties and drug-likeness score.
Similar content being viewed by others
References
Chabner BA, Roberts TG (2005) Chemotherapy and the war on cancer. Nat Rev Cancer 5:65–72. https://doi.org/10.1038/nrc1529
Allen TM, Cullis PR (2004) Drug delivery systems: entering the mainstream. Science 303:1818–1822. https://doi.org/10.1126/science.1095833
Rosen H, Abribat T (2005) The rise and rise of drug delivery. Nat Rev Drug Discov 4:381–385. https://doi.org/10.1038/nrd1721
Mikov M, Fawcett J, Kuhajda K, Kevresan S (2006) Pharmacology of bile acids and their derivatives: absorption promoters and therapeutic agents. Eur J Drug Metab Pharmacokinet 31:237–251. https://doi.org/10.1007/BF03190714
Segal NH, Saltz LB (2009) Evolving treatment of advanced colon cancer. Annu Rev Med 60:207–219. https://doi.org/10.1146/annurev.med.60.041807.132435
Saltz LB (2010) Adjuvant therapy for colon cancer. Surg Oncol Clin N Am 19:819–827. https://doi.org/10.3322/canjclin.49.4.202
Mukhopadhyay S, Maitra U (2004) Chemistry and biology of bile acids. Curr Sci 87:1666–1683 ISSN 0011-3891
Tolle-Sander S, Lentz KA, Maeda DY, Coop A, Polli JE (2004) Increased acyclovir oral bioavailability via a bile acid conjugate. Mol Pharm 1:40–48. https://doi.org/10.1021/mp034010t
Xiao K, Luo J, Fowler WL, Li Y, Lee JS, Xing L, Cheng RH, Wang L, Lam KS (2009) A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer. Biomaterials 30:6006–6016. https://doi.org/10.1016/j.biomaterials.2009.07.015
Sreekanth V, Bansal S, Motiani RK, Kundu S, Muppu SK, Majumdar TD, Panjamurthy K, Sengupta S, Bajaj A (2013) Design, synthesis, and mechanistic investigations of bile acid-tamoxifen conjugates for breast cancer therapy. Bioconjug Chem 24:1468–1484. https://doi.org/10.1021/bc300664k
Festi D, Montagnani M, Azzaroli F, Lodato F, Mazzella G, Roda A, Rita Di Biase A, Roda E, Simoni P, Colecchia A (2007) Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. Curr Clin Pharmacol 2:155–177. https://doi.org/10.2174/157488407780598171
Choi YH, Im EO, Suh H, Jin Y, Yoo YH, Kim ND (2003) Apoptosis and modulation of cell cycle control by synthetic derivatives of ursodeoxycholic acid and chenodeoxycholic acid in human prostate cancer cells. Cancer Lett 199:157–167. https://doi.org/10.1016/S0304-3835(03)00351-3
Alberts DS, Martínez ME, Hess LM, Einspahr JG, Green SB, Bhattacharyya AK, Guillen J, Krutzsch M, Batta AK, Salen G (2005) Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J Natl Cancer Inst 97:846–853. https://doi.org/10.1093/jnci/dji144
Su-Bogyee W, Park BS, Kim JY, Soojinbaek Y, Seo SY, Lee SH, Kim JH, Hongsuksuh NDK, Lim YJ, Yoo YH (2005) Synthetic chenodeoxycholic acid derivatives inhibit glioblastoma multiform tumor growth in vitro and in vivo. Int J Oncol 27:653–659. https://doi.org/10.3892/ijo.27.3.653
Park SE, Choi HJ, Yee SB, Chung HY, Suh H, Choi YH, Yoo YH, Kim ND (2004) Synthetic bile acid derivatives inhibit cell proliferation and induce apoptosis in HT-29 human colon cancer cells. Int J Oncol 25:231–236. https://doi.org/10.3892/ijo.25.1.231
Im EO, Choi YH, Paik K-J, Suh H, Jin Y, Kim K-W, Yoo YH, Kim ND (2001) Novel bile acid derivatives induce apoptosis via a p53-independent pathway in human breast carcinoma cells. Cancer Lett 163:83–93. https://doi.org/10.1016/S0304-3835(00)00671-6
Choi YH, Im E-O, Suh H, Jin Y, Lee W, Yoo YH, Kim K-W, Kim N (2001) Apoptotic activity of novel bile acid derivatives in human leukemic T cells through the activation of caspases. Int J Oncol 18:979–984. https://doi.org/10.3892/ijo.18.5.979
Im E, Choi S-H, Suh H, Choi YH, Yoo YH, Kim ND (2005) Synthetic bile acid derivatives induce apoptosis through a c-Jun N-terminal kinase and NF-\(\kappa \)B-dependent process in human cervical carcinoma cells. Cancer Lett 229:49–57. https://doi.org/10.1016/j.canlet.2004.11.055
Park SE, Lee SW, Hossain MA, Kim MY, Kim M-N, Ahn EY, Park YC, Suh H, Kim G-Y, Choi YH (2008) A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells. Cancer Lett 270:77–86. https://doi.org/10.1016/j.canlet.2008.04.038
Ramalho RM, Viana RJ, Low WC, Steer CJ, Rodrigues CM (2008) Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer’s disease. Trends Mol Med 14:54–62. https://doi.org/10.1016/j.molmed.2007.12.001
Brossard D, El Kihel L, Clément M, Sebbahi W, Khalid M, Roussakis C, Rault S (2010) Synthesis of bile acid derivatives and in vitro cytotoxic activity with pro-apoptotic process on multiple myeloma (KMS-11), glioblastoma multiforme (GBM), and colonic carcinoma (HCT-116) human cell lines. Eur J Med Chem 45:2912–2918. https://doi.org/10.1016/j.ejmech.2010.03.016
Brossard D, Lechevrel M, El Kihel L, Quesnelle C, Khalid M, Moslemi S, Reimund J-M (2014) Synthesis and biological evaluation of bile carboxamide derivatives with pro-apoptotic effect on human colon adenocarcinoma cell lines. Eur J Med Chem 86:279–290. https://doi.org/10.1016/j.ejmech.2014.07.080
Agarwal DS, Anantaraju HS, Sriram D, Yogeeswari P, Nanjegowda SH, Mallu P, Sakhuja R (2016) Synthesis, characterization and biological evaluation of bile acid-aromatic/heteroaromatic amides linked via amino acids as anti-cancer agents. Steroids 107:87–97. https://doi.org/10.1016/j.steroids.2015.12.022
Liu Y, Liu Y, Chen H, Yao X, Xiao Y, Zeng X, Zheng Q, Wei Y, Song C, Zhang Y (2015) Synthetic resveratrol derivatives and their biological activities: a review. Open J Med Chem 5:97–105. https://doi.org/10.4236/ojmc.2015.54006
Tarleton M, Gilbert J, Robertson MJ, McCluskey A, Sakoff JA (2011) Library synthesis and cytotoxicity of a family of 2-phenylacrylonitriles and discovery of an estrogen dependent breast cancer lead compound. MedChemComm 2:31–37. https://doi.org/10.1039/C0MD00147C
Penthala NR, Sonar VN, Horn J, Leggas M, Yadlapalli JSK, Crooks PA (2013) Synthesis and evaluation of a series of benzothiophene acrylonitrile analogs as anticancer agents. MedChemComm 4:1073–1078. https://doi.org/10.1039/C3MD00130J
Ohsumi K, Nakagawa R, Fukuda Y, Hatanaka T, Morinaga Y, Nihei Y, Ohishi K, Suga Y, Akiyama Y, Tsuji T (1998) Novel combretastatin analogs effective against murine solid tumors: design and structure-activity relationships. J Med Chem 41:3022–3032. https://doi.org/10.1021/jm980101w
Penthala NR, Thakkar S, Crooks PA (2015) Heteroaromatic analogs of the resveratrol analog DMU-212 as potent anti-cancer agents. Bioorg Med Chem Lett 25:2763–2767. https://doi.org/10.1016/j.bmcl.2015.05.019
Alam MS, Nam Y-J, Lee D-U (2013) Synthesis and evaluation of (Z)-2, 3-diphenylacrylonitrile analogs as anti-cancer and anti-microbial agents. Eur J Med Chem 69:790–797. https://doi.org/10.1016/j.ejmech.2013.08.031
Gomes CMF, van Paassen H, Romeo S, Welling MM, Feitsma R, Abrunhosa AJ, Botelho MF, Hogendoorn PC, Pauwels E, Cleton-Jansen AM (2006) Multidrug resistance mediated by ABC transporters in osteosarcoma cell lines: mRNA analysis and functional radiotracer studies. Nucl Med Biol 33:831–840. https://doi.org/10.1016/j.nucmedbio.2006.07.011
Molinspiration Cheminformatics, Nova ulica, SK-900 26 Slovensky Grob, Slovak Republic. http://www.molinspiration.com
Zhao YH, Abraham MH, Le J, Hersey A, Luscombe CN, Beck G, Sherborne B, Cooper I (2002) Rate-limited steps of human oral absorption and QSAR studies. Pharm Res 19:1446–1457. https://doi.org/10.1023/A:1020444330011
Maximo da Silva M, Comin M, Santos Duarte T, Foglio MA, de Carvalho JE, do Carmo Vieira M, Nazari Formagio AS (2015) Synthesis, antiproliferative activity and molecular properties predictions of galloyl derivatives. Molecules 20:5360–5373. https://doi.org/10.3390/molecules20045360
Molsoft LLC, 1199 Sorrento Valley Road, S209 San Diego CA 92121, USA. https://www.molsoft.com
Penthala NR, Zong H, Ketkar A, Madadi NR, Janganati V, Eoff RL, Guzman L, Crooks PA (2015) Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogs as antitubulin agents. Eur J Med Chem 92:212–220. https://doi.org/10.1016/j.ejmech.2014.12.050
Lai X-Z, Feng Y, Pollard J, Chin JN, Rybak MJ, Bucki R, Epand RF, Epand RM, Savage PB (2008) Ceragenins: cholic acid-based mimics of antimicrobial peptides. Acc Chem Res 41:1233–1240. https://doi.org/10.1021/ar700270t
Parveen M, Malla AM, Alam M, Ahmad M, Rafiq S (2014) Stereoselective synthesis of Z-acrylonitrile derivatives: catalytic and acetylcholinesterase inhibition studies. New J Chem 38:1655–1667. https://doi.org/10.1039/C3NJ01384G
Chowdhury R, Chowdhury S, Roychoudhury P, Mandal C, Chaudhuri K (2009) Arsenic induced apoptosis in malignant melanoma cells is enhanced by menadione through ROS generation, p38 signaling and p53 activation. Apoptosis 14:108–123. https://doi.org/10.1007/s10495-008-0284-8
Othman N, In LLA, Harikrishna JA, Hasima N (2013) Bcl-xL silencing induces alterations in hsa-miR-608 expression and subsequent cell death in A549 and SKLU1 human lung adenocarcinoma cells. PLoS ONE 8:e81735
Agnihotri S, Mukherji S, Mukherji S (2014) Size-controlled silver nanoparticles synthesized over the range 5–100 nm using the same protocol and their antibacterial efficacy. RSC Adv 4:3974–3983. https://doi.org/10.1039/C3RA44507K
Acknowledgements
The author RS would like to acknowledge Birla Institute of Technology and Science (BITS), Pilani, for providing additional research grant. The author DA is thankful to DST, New Delhi, for providing Senior Research Fellowship. We also like to thank central NMR facility BITS Pilani. The authors also sincerely acknowledge financial support from DST under FIST program [Project: SR/FST/CSI-270/2015] for HRMS facility.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Agarwal, D.S., Singh, R.P., Lohitesh, K. et al. Synthesis and evaluation of bile acid amides of \(\alpha \)-cyanostilbenes as anticancer agents. Mol Divers 22, 305–321 (2018). https://doi.org/10.1007/s11030-017-9797-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11030-017-9797-9